8-124553366-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014751.6(MTSS1):āc.1894G>Cā(p.Ala632Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000344 in 1,611,616 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014751.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTSS1 | NM_014751.6 | c.1894G>C | p.Ala632Pro | missense_variant | 14/14 | ENST00000518547.6 | NP_055566.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTSS1 | ENST00000518547.6 | c.1894G>C | p.Ala632Pro | missense_variant | 14/14 | 1 | NM_014751.6 | ENSP00000429064 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000499 AC: 125AN: 250364Hom.: 1 AF XY: 0.000473 AC XY: 64AN XY: 135268
GnomAD4 exome AF: 0.000342 AC: 499AN: 1459462Hom.: 2 Cov.: 32 AF XY: 0.000353 AC XY: 256AN XY: 725562
GnomAD4 genome AF: 0.000361 AC: 55AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.1894G>C (p.A632P) alteration is located in exon 14 (coding exon 14) of the MTSS1 gene. This alteration results from a G to C substitution at nucleotide position 1894, causing the alanine (A) at amino acid position 632 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at